Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 1 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 1

From: Role of 18F-FDG PET/CT in assessment of HCC patients after therapeutic interventions compared to DW MRI

Fig. 1

A 66-year-old female patient with a history of segment VII HCC, underwent TACE. TR-LR viable lesion with increased FDG uptake and diffusion restriction, as well as mildly active metastatic pulmonary nodule, with no de novo lesions. MIP image (A) showing focal hepatic right lobar upper segmental increased tracer uptake. Arterial (B) and delayed (C) triphasic CT showing partial lipiodol retention, and residual/recurrent viable tumoral tissue (white arrow) shows APHE and washout. DWI (D) and ADC map (E) shows restricted diffusion in the embolized HCC (white arrow) with mean ADC value measuring 991 mm2/s. Fused PET/CT study shows peripheral increased FDG uptake in the embolized HCC (white arrow) achieving SUVmax of 6.4 (F) and mild FDG uptake in a pulmonary nodule (white arrow) (G)

Back to article page